TSVT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TSVT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Retained earnings is the accumulated portion of net income that is not distributed to shareholders. 2seventy bio's retained earnings for the quarter that ended in Mar. 2024 was $-563.89 Mil.
2seventy bio's quarterly retained earnings declined from Sep. 2023 ($-454.40 Mil) to Dec. 2023 ($-511.22 Mil) and declined from Dec. 2023 ($-511.22 Mil) to Mar. 2024 ($-563.89 Mil).
2seventy bio's annual retained earnings declined from Dec. 2021 ($-39.49 Mil) to Dec. 2022 ($-293.65 Mil) and declined from Dec. 2022 ($-293.65 Mil) to Dec. 2023 ($-511.22 Mil).
The historical data trend for 2seventy bio's Retained Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2seventy bio Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Retained Earnings | Get a 7-Day Free Trial | - | - | -39.49 | -293.65 | -511.22 |
2seventy bio Quarterly Data | ||||||||||||||||||
Dec18 | Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Retained Earnings | Get a 7-Day Free Trial | -340.67 | -382.76 | -454.40 | -511.22 | -563.89 |
Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.
Of course, if a company loses, it is called retained losses, or accumulated losses.
2seventy bio (NAS:TSVT) Retained Earnings Explanation
Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.
For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.
If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.
Of course, many companies with negative retained earnings have indeed lost money in the past.
Retained Earnings: Warren Buffett's Secret.
One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.
If the company loses more than it has accumulated, retained earnings is negative.
If a company isn't adding to its retained earnings, it isn't growing its net worth.
Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.
Microsoft is negative because it chose to buyback stock and pay dividends.
The more earnings retained, the faster it grows and increases growth rate for future earnings.
Nick Leschly | director, officer: President and CEO | C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Philip D Gregory | officer: Chief Scientific Officer | POINT RICHMOND TECH CENTER II, 501 CANAL BOULEVARD SUITE A100, RICHMOND CA 94804 |
Baird William D Iii | officer: Chief Financial Officer | C/O BLUEBIRD BIO, INC., 60 BINNEY STREET, CAMBRIDGE MA 02142 |
Yue Tang | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Kynam Fund Gp, Llc | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Kynam Global Healthcare Master Fund, Lp | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Kynam Capital Management Gp, Llc | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Kynam Capital Management, Lp | 10 percent owner | 221 ELM ROAD, PRINCETON NJ 08540 |
Lin Wei | director | C/O ERASCA, INC., 10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO CA 92121 |
Nicola Heffron | officer: Chief Operating Officer | 2SEVENTY BIO, INC., 60 BINNEY STREET, CAMBRIDGE MA 02142 |
Marcela V. Maus | director | 16 RICHMOND CIRCLE, LEXINGTON MA 02421 |
Ramy Ibrahim | director | C/O SURFACE ONCOLOGY, 50 HAMPSHIRE STREET, 8TH FLOOR, CAMBRIDGE MA 02139 |
Sarah Js Glickman | director | 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142 |
Daniel Lynch | director | |
Denice Torres | director | 3 RABBIT RUN DRIVE, NEW HOPE PA 18938 |
From GuruFocus
By Stock market mentor Stock market mentor • 01-18-2023
By Business Wire • 09-12-2023
By Business Wire Business Wire • 05-11-2023
By Business Wire • 08-14-2023
By Business Wire Business Wire • 11-03-2022
By Business Wire • 08-01-2023
By Business Wire Business Wire • 11-07-2022
By Business Wire Business Wire • 10-27-2022
By Business Wire Business Wire • 02-28-2023
By Business Wire • 09-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.